Friday, October 19, 2018 2:32:51 PM
FALLACY of Investors: SCIENTIFICALLY focused on the TREES (science)and clear disregard for the FOREST(Investment process/discipline etc): to NOT expect DILUTION from the end of 2015 says it ALL! especially with clinical halt
Everyone LOST PERSPECTIVE of the INVESTMENT PROCESS:
Emerging Biotechs have an INSATIABLE FUNDING NEED. Investors got bowled over with Neil Woodford's $190 mln in funding with an average per share cost near $7 (driving the stock to $12) AND MISSED his lack of credentials in that space. Sure he is Europe's Warren Buffet with his track record at INVESCO with industrials and some Big Pharma experience but Neil Woodford invested at the height of euphoria with emerging biotech space.
With Neil Woodford funding, CEO Linda Powers made a BOLD statement in her Sept 2015 Citytrust interview:" We are going it alone: Big Pharma has nothing to offer us but money": GO BIG OR GO HOME! With the Nov 2015 Ondra Affair when the stock was $4-$5 everyone should have SOLD! Guilty of lack of critical investment judgement let alone lack of investment DISCIPLINE owing to novice status: With the Governance suit/Cognate etc former financial partner Woodford and funds were clearly doing an underhanded raid on NWBO. So this board and ALL large holders still here as I've indicated got lost in the trees: Without $ funding and adept shorts and manipulators going full throttle OVERWHELM everyone in their own spoils and CEO Linda Powers has had to deal with a TITANIC.
So each of you could do all the subterfuging; camouflaging; obfuscation; spinning and cover ups and blame game thru your scientific tinkering on this board and Yahoo.
INVESTMENT EXPERIENCE in ALL the relevant areas with DEPTH pays unlike the 3-4 years of inner turmoil of lost of life savings; lost opportunity costs with the longest bull market in history that it has produced for many here. I haven't lost any money here, generated a 60% return from $6-$10 never had a restless night of sleep over NWBO where so many spend their 24/7/365 timeline.
CEO Linda Powers has to unshackle us (unblinding top line DC VAX L results along with partnering deal(S) are complex, time consuming affairs) from that albatross period from FALL 2015 for ALL from her inner circle to patients. Hopefully it will be her second and last attempt from the Ashes to the final Phoenix.
IMHO only.
DIFFERENT STROKES FOR DIFFERENT FOLKS
Everyone LOST PERSPECTIVE of the INVESTMENT PROCESS:
Emerging Biotechs have an INSATIABLE FUNDING NEED. Investors got bowled over with Neil Woodford's $190 mln in funding with an average per share cost near $7 (driving the stock to $12) AND MISSED his lack of credentials in that space. Sure he is Europe's Warren Buffet with his track record at INVESCO with industrials and some Big Pharma experience but Neil Woodford invested at the height of euphoria with emerging biotech space.
With Neil Woodford funding, CEO Linda Powers made a BOLD statement in her Sept 2015 Citytrust interview:" We are going it alone: Big Pharma has nothing to offer us but money": GO BIG OR GO HOME! With the Nov 2015 Ondra Affair when the stock was $4-$5 everyone should have SOLD! Guilty of lack of critical investment judgement let alone lack of investment DISCIPLINE owing to novice status: With the Governance suit/Cognate etc former financial partner Woodford and funds were clearly doing an underhanded raid on NWBO. So this board and ALL large holders still here as I've indicated got lost in the trees: Without $ funding and adept shorts and manipulators going full throttle OVERWHELM everyone in their own spoils and CEO Linda Powers has had to deal with a TITANIC.
So each of you could do all the subterfuging; camouflaging; obfuscation; spinning and cover ups and blame game thru your scientific tinkering on this board and Yahoo.
INVESTMENT EXPERIENCE in ALL the relevant areas with DEPTH pays unlike the 3-4 years of inner turmoil of lost of life savings; lost opportunity costs with the longest bull market in history that it has produced for many here. I haven't lost any money here, generated a 60% return from $6-$10 never had a restless night of sleep over NWBO where so many spend their 24/7/365 timeline.
CEO Linda Powers has to unshackle us (unblinding top line DC VAX L results along with partnering deal(S) are complex, time consuming affairs) from that albatross period from FALL 2015 for ALL from her inner circle to patients. Hopefully it will be her second and last attempt from the Ashes to the final Phoenix.
IMHO only.
DIFFERENT STROKES FOR DIFFERENT FOLKS
DIFFERENT STROKES FOR DIFFERENT FOLKS
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
